IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 50 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,865,203 | -5.6% | 1,384,686 | +9.0% | 4.88% | -17.1% |
| Q2 2023 | $76,156,635 | +36.8% | 1,270,124 | +12.8% | 5.88% | +11.5% |
| Q1 2023 | $55,682,097 | +13.7% | 1,126,256 | +31.3% | 5.28% | -8.2% |
| Q4 2022 | $48,961,780 | +34.9% | 857,925 | +11.0% | 5.75% | +18.8% |
| Q3 2022 | $36,288,000 | +45.7% | 773,079 | +15.8% | 4.84% | -2.6% |
| Q2 2022 | $24,901,000 | +66.8% | 667,417 | +33.7% | 4.96% | +25.8% |
| Q1 2022 | $14,926,000 | +224.7% | 499,190 | +271.8% | 3.95% | +200.6% |
| Q4 2021 | $4,597,000 | – | 134,249 | – | 1.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |